HCW Biologics annual total assets
2020
2021
2022
2023
2024
2025
HCW Biologics Total Assets Growth & History (HCWB)
HCW Biologics's total assets was $24.5M for fiscal 2025.
View full HCW Biologics company overviewHCW Biologics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $24.5M | −$5.7M | −18.91% |
| 2024 | 2024-12-31 | $30.2M | $1.7M | +6.04% |
| 2023 | 2023-12-31 | $28.5M | −$18.3M | −39.09% |
| 2022 | 2022-12-31 | $46.8M | −$6.7M | −12.53% |
| 2021 | 2021-12-31 | $53.5M | $38.1M | +247.54% |
| 2020 | 2020-12-31 | $15.4M | — | — |
HCW Biologics quarterly total assets
Q4.20
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $26.8M | −$2.1M | −7.41% |
| Q1 2026 | 2026-03-31 | $27.3M | $1.1M | +4.02% |
| Q4 2025 | 2025-12-31 | $24.5M | −$5.7M | −18.91% |
| Q3 2025 | 2025-09-30 | $25.4M | −$1.1M | −4.18% |
| Q2 2025 | 2025-06-30 | $28.9M | $2.1M | +7.79% |
| Q1 2025 | 2025-03-31 | $26.3M | −$4.1M | −13.61% |
| Q4 2024 | 2024-12-31 | $30.2M | $1.7M | +6.04% |
| Q3 2024 | 2024-09-30 | $26.6M | −$9.1M | −25.44% |
| Q2 2024 | 2024-06-30 | $26.8M | −$12.7M | −32.07% |
| Q1 2024 | 2024-03-31 | $30.4M | −$13.1M | −30.11% |
| Q4 2023 | 2023-12-31 | $28.5M | −$18.3M | −39.09% |
| Q3 2023 | 2023-09-30 | $35.6M | −$15.7M | −30.64% |
| Q2 2023 | 2023-06-30 | $39.5M | −$7.9M | −16.72% |
| Q1 2023 | 2023-03-31 | $43.5M | −$7.4M | −14.56% |
| Q4 2022 | 2022-12-31 | $46.8M | −$6.7M | −12.53% |
| Q3 2022 | 2022-09-30 | $51.4M | −$5.1M | −8.96% |
| Q2 2022 | 2022-06-30 | $47.4M | $34.4M | +263.75% |
| Q1 2022 | 2022-03-31 | $51.0M | — | — |
| Q4 2021 | 2021-12-31 | $53.5M | $38.1M | +247.54% |
| Q3 2021 | 2021-09-30 | $56.4M | — | — |
| Q2 2021 | 2021-06-30 | $13.0M | — | — |
| Q4 2020 | 2020-12-31 | $15.4M | — | — |
HCW Biologics total assets trends
Over the last five fiscal years, HCW Biologics's total assets increased from $15.4M to $24.5M, a change of $9.1M. The latest reported quarter, Q2 2026, shows $26.8M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review HCW Biologics source filings ↗